{"title":"Probing Anticancer Molecules from Onion Peels Waste; First Synthesis and Biological Studies of a Rare Quercetin Derivative-Pachypodol","authors":"Pandurangan Nanjan, Jyotsna Nambiar, Chinchu Bose, Asoke Banerji, Bipin G. Nair","doi":"10.2174/0115734072293689240219110806","DOIUrl":null,"url":null,"abstract":"\n\nThe constant increase in global onion production escalates the generation\nof onion peel waste. For instance, globally, >50 lakh tons of onion waste are generated annually.\n\n\n\nIts objectionable odor precludes its use in agriculture or disposal as landfilling presents\nenvironmental issues. Previous studies show that two major flavonoids, quercetin and its glycosides\n(spiraeoside), have been identified in abundance in onion waste. By utilizing the spiraeoside\n(quercetin-4ʹ-glucoside), a rapid synthesis of pachypodol (quercetin-3,3′,7-trimethyl ether, and a\nrare flavonol), an essential Ayurvedic product, has been developed and achieved. Pachypodol and\nanalogs were studied for their ability to inhibit matrix metalloproteinase-2 and -9 (MMP-2 & 9)\nactivity. Amongst the compounds tested, pachypodol significantly inhibited MMP-2 activity.\n\n\n\nIn-silico docking studies suggest that, unlike most known MMP inhibitors, pachypodol\ninteracts selectively with MMP-2 through the residues Ile222, Tyr223, and Thr227 in a zincindependent\nmanner.\n\n\n\nThe experimental studies also prove that pachypodol inhibits the MMP-2 enzyme in\na zinc-independent way.\n","PeriodicalId":10772,"journal":{"name":"Current Bioactive Compounds","volume":"84 3","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Bioactive Compounds","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/0115734072293689240219110806","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 0
Abstract
The constant increase in global onion production escalates the generation
of onion peel waste. For instance, globally, >50 lakh tons of onion waste are generated annually.
Its objectionable odor precludes its use in agriculture or disposal as landfilling presents
environmental issues. Previous studies show that two major flavonoids, quercetin and its glycosides
(spiraeoside), have been identified in abundance in onion waste. By utilizing the spiraeoside
(quercetin-4ʹ-glucoside), a rapid synthesis of pachypodol (quercetin-3,3′,7-trimethyl ether, and a
rare flavonol), an essential Ayurvedic product, has been developed and achieved. Pachypodol and
analogs were studied for their ability to inhibit matrix metalloproteinase-2 and -9 (MMP-2 & 9)
activity. Amongst the compounds tested, pachypodol significantly inhibited MMP-2 activity.
In-silico docking studies suggest that, unlike most known MMP inhibitors, pachypodol
interacts selectively with MMP-2 through the residues Ile222, Tyr223, and Thr227 in a zincindependent
manner.
The experimental studies also prove that pachypodol inhibits the MMP-2 enzyme in
a zinc-independent way.
Current Bioactive CompoundsPharmacology, Toxicology and Pharmaceutics-Pharmacology, Toxicology and Pharmaceutics (all)
CiteScore
1.90
自引率
0.00%
发文量
112
期刊介绍:
The journal aims to provide comprehensive review articles on new bioactive compounds with proven activities in various biological screenings and pharmacological models with a special emphasis on stereoeselective synthesis. The aim is to provide a valuable information source of bioactive compounds synthesized or isolated, which can be used for further development of pharmaceuticals by industry and academia. The journal should prove to be essential reading for pharmacologists, natural product chemists and medicinal chemists who wish to be kept informed and up-to-date with the most important developments on new bioactive compounds of natural or synthetic origin, including their stereoeselective synthesis.